Introduction: Septic dural-sinus thrombosis is rare; it is one of the most misdiagnosed conditions of our time. It is often associated with a high level of mortality. Especially in neonates who have an underdeveloped immune system and haphazard clinical manifestation. Septic sinus thrombosis frequently involves cavernous sinuses. The superior sagittal sinuses' involvement is exceptional as it is often associated with a fatal outcome. Studies demonstrate that heparin therapy in sagittal sinus septic thrombosis is unnecessary and that the focus of treatment shall be intravenous antibiotics and early surgical drainage of purulent collections who can be a source of widespread infections. Case Report: We report the case of a three months old boy, without pathological history, admitted in the intensive care unit (ICU) for febrile convulsion resistant to first line therapy. Cerebrospinal fluid analysis results were in favor of pneumococcus pathogens. Cerebral computed tomography (CT) has shown a superior longitudinal sinus thrombophlebitis complicating an encephalitis, with multiple venous infarcts. After which antibiotherapy was changed and anticoagulation
The management of patients with cancer, presenting an immediate life-threatening risk is a complex and controversial subject. The admission of those patients to the care unit poses a real dilemma, we are torn between the desire to go to the limits of technical possibilities especialy for young patients. Materials and methods: We report 4 cases of patients, admitted in intensive care unit for respiratory distress causes by a tumor. These patients were intubation because of hypoxemia, and then received curative chemotherapy in the intensive care unit. Discussion: A few years ago, admission to intensive care unit for oncohematology patients was unthinkable. It still is nowadays, we are torn between the desires to go to the limits of technical possibilities especialy for young patients. A study of ICU admissions for any type of lung carcinoma (80% of Non-Small Cell Bronchial Cancers) shows that of the 22,538 patients in stages III-IV, 16360 leave the hospital and 4,889 survive at 6 months. Only 11% of mechanically ventilated patients leave the hospital. In our study, one of the four patients treated with chemotherapy responded well, a ratio of 25%. Conclusion: Admission decisions of patient with neoplasia to the ICU should be made on a case-by-case basis, somewhere between the two ends of the decision-making spectrum, based on the clinical evaluation and after discussions with the oncologist and patient
Introduction: Esotracheal fistulas in adults are rare (fewer than 30 cases in the literature) and few cases have been reported in recent years. Hodgkin's disease with esotracheal fistula is extremely rare. The diagnosis can be established by esophageal and/or tracheal endoscopy. The diagnosis can also be corroborated by direct visualization of a fistulous pathway or oral contrast swallow associated with computed tomography (CT) imaging. Case Report: We present the case of a 27-year-old patient followed for Hodgkin's disease, admitted to the emergency room with respiratory failure. He did not respond to treatment by mechanical ventilation. His paraclinical investigations revealed an esotracheal fistula. Conclusion: Esotracheal or esobronchial fistula could be seen with any of the classical Hodgkin's lymphoma subtypes. It could also be a complication of either radiotherapy (RT) or chemotherapy for Hodgkin's lymphoma which is an extremely rare event. The majority of fistulas occurred in the upper two-thirds
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.